Delivery Order SPE2DR25D2006-SPE2DR26F57SL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,879.64 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3mL) on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price contract is non-competitive with no set-aside designation and will be performed at the company's headquarters in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,534.66 to AmerisourceBergen Drug Corp for the supply of Miebo 100% Eye Drop (3ml) on January 6, 2026, with completion anticipated by January 7, 2026. This non-set-aside, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,009.99 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drops in a 3 mL quantity. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 6, 2026. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $19,102.14 to AmerisourceBergen Drug Corp for the supply of MIEBO 100% eye drops (3 mL) on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract employs firm fixed-price pricing and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $1,256.89 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on January 2, 2026, with completion targeted for January 5, 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drops (3 milliliter units) on December 11, 2025, with a completion date of December 12, 2025. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.99 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop medication in a 3 milliliter formulation. The award, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerisourceBergen Drug Corp. This delivery...
- The Defense Logistics Agency awarded a $3,769.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Miebo 100% eye drop solution in 3 mL units. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by October 31, 2025. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $36,483.26. This firm fixed-price delivery order, which is not set-aside for any special contracting category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a $8,796.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on January 5, 2026, with completion scheduled for January 6, 2026. This award was competitively procured with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57SLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,122.82 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop (3mL) on January 27, 2026, with an ultimate completion date of January 28, 2026. This non-set-aside competitive award is structured as a firm fixed-price delivery order and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Miebo eye drops is consistent with the company's role in fulfilling essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/26/26 |